Tempus is a brand that has revolutionized the field of precision medicine by building the world's largest library of clinical and molecular data. Their primary focus is on cancer, utilizing advanced technology and artificial intelligence (AI) to make data accessible and useful. With their AI-enabled platform, Tempus provides a range of products and services to various stakeholders in the healthcare industry.

For providers, Tempus offers genomic profiling, algorithmic tests, clinical trial matching, digital pathology, and financial assistance to help physicians make more informed treatment decisions. They also cater to the needs of life sciences companies, providing assistance with drug development through sequencing data, collaborations, and clinical research organization services. Patients can benefit from Tempus by gaining access to personalized therapy options and clinical trials in oncology, neurology, and psychiatry.

Tempus takes pride in its scientific contributions, with research projects and publications that accelerate and transform personalized patient care. Their impressive network includes collaborations with academic medical centers, oncologists, and pharma companies to improve patient outcomes. With a commitment to AI-enabled precision medicine, Tempus is at the forefront of shaping the future of healthcare.

Explore their resources, research, and platform to discover the unique ways they are revolutionizing the field